Literature DB >> 21763000

Community attitudes to genetic susceptibility-based mental health interventions for healthy people in a large national sample.

Alex Wilde1, Bettina Meiser, Philip B Mitchell, Peter R Schofield.   

Abstract

BACKGROUND: Despite an apparent high interest in predictive genetic testing for common multifactorial disorders, few data describe anticipated health behaviour as a consequence of such testing.
METHODS: A large population-based public survey with community dwelling adults (N = 1046) ascertained through random digit dialling. Attitudes were assessed via structured interviews.
RESULTS: Intention to start therapies or courses to learn to develop better strategies to cope with stress (80%) was significantly and positively associated with self-estimation of risk for major depressive disorder as higher than average (ß = 0.12, p = 0.001); endorsement of family environment as a causal attribution (ß = 0.11, p < 0.001); and endorsement of gene-environment interaction as a causal mechanism of mental illness (ß = 0.12, p = 0.017). Intention to modify potential life stressors (84%) was significantly and positively associated with self-estimation of risk for depression as higher than average (ß = 0.07, p = 0.029); endorsement of 'abuse' as a causal attribution (ß = 0.10, p = 0.003); and endorsement of 'gene-environment interaction' as a causal mechanism (ß = 0.10, p = 0.002). LIMITATIONS: The hypothetical nature of the genetic risk scenario may have weakened participants' sensitivity to the potential personal impact of such a genetic test result.
CONCLUSIONS: Perceptions that modifiable environmental factors strongly contribute to overall risk of major depressive disorder appeared to drive willingness to engage in risk-modifying interventions in the hypothetical scenario of a genetic predisposition. Our results suggest that screening for genetic risk in consort with environmental risk factor assessment has potential community acceptability and clinical value as an early intervention and preventive tool for high risk groups.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21763000     DOI: 10.1016/j.jad.2011.06.023

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

1.  Attitudes towards cannabis use and genetic testing for schizophrenia.

Authors:  Jason Schiffman; Ryan E Lawrence; Caroline Demro; Paul S Appelbaum; Lisa B Dixon
Journal:  Early Interv Psychiatry       Date:  2014-06-23       Impact factor: 2.732

2.  A Genomically Informed Education System? Challenges for Behavioral Genetics.

Authors:  Maya Sabatello
Journal:  J Law Med Ethics       Date:  2018-03-27       Impact factor: 1.718

3.  Exploring culture-specific differences in beliefs about causes, kinship and the heritability of major depressive disorder: the views of Anglo-Celtic and Chinese-Australians.

Authors:  Mimi Xu; Lilian Zou; Alex Wilde; Bettina Meiser; Kristine Barlow-Stewart; Bibiana Chan; Philip B Mitchell; Mariana S Sousa; Peter R Schofield
Journal:  J Genet Couns       Date:  2013-05-17       Impact factor: 2.537

4.  Genetic attribution and perceived impact of epilepsy in multiplex epilepsy families.

Authors:  Diana C Garofalo; Shawn T Sorge; Dale C Hesdorffer; Melodie R Winawer; Jo C Phelan; Wendy K Chung; Ruth Ottman
Journal:  Epilepsia       Date:  2019-10-06       Impact factor: 5.864

5.  Genomic sequencing for psychiatric disorders: promise and challenge.

Authors:  Barbara Bowles Biesecker; Holly Landrum Peay
Journal:  Int J Neuropsychopharmacol       Date:  2013-04-10       Impact factor: 5.176

6.  Predictive Psychiatric Genetic Testing in Minors: An Exploration of the Non-Medical Benefits.

Authors:  Arianna Manzini; Danya F Vears
Journal:  J Bioeth Inq       Date:  2017-12-11       Impact factor: 1.352

7.  Cluster randomized controlled trial of a psycho-educational intervention for people with a family history of depression for use in general practice.

Authors:  Bettina Meiser; Peter R Schofield; Lyndal Trevena; Alex Wilde; Kristine Barlow-Stewart; Judy Proudfoot; Michelle Peate; Timothy Dobbins; Helen Christensen; Kerry A Sherman; Janan Karatas; Philip B Mitchell
Journal:  BMC Psychiatry       Date:  2013-12-01       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.